ColoGen
The ColoGen test is a genetic analysis that allows for the assessment of the relative risk of sporadic colorectal cancer (CRC) or whether an individual has one or more risk genes associated with this form of CRC
ABOUT COLOGEN
Colorectal carcinoma (CRC) is a common form of cancer with a high mortality rate if not detected at an early stage when it is still benign. The risk of developing colorectal cancer can be reduced by strictly adhering to the provided recommendations.
WHO AND WHEN SHOULD BE TESTED?
ColoGen is primarily intended for older individuals. The degeneration of a benign polyp into a malignant tumor occurs very slowly, over a period of 10 to 15 years. Early testing to assess risk factors is recommended.
RESULTS AND INTERPRETATION
ColoGen is based exclusively on genetic analysis conducted using a blood or saliva sample.
– Detailed individual results that are valid for a lifetime.
– A personalized report that considers both genetic and non-genetic predispositions.
– The main methods for addressing or preventing CRC-related conditions.
– Personalized recommendations for nutrition and lifestyle.